These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 33221245)

  • 21. Causes of false-negative for high-grade urothelial carcinoma in urine cytology.
    Lee PJ; Owens CL; Lithgow MY; Jiang Z; Fischer AH
    Diagn Cytopathol; 2016 Dec; 44(12):994-999. PubMed ID: 27781412
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Implementation of The Paris System for Reporting Urine Cytology improves diagnostic accuracy of selective upper urinary tract cytology.
    Miyai K; Nakayama M; Minabe S; Ogata S; Ito K; Matsukuma S
    Cancer Cytopathol; 2024 Apr; 132(4):242-249. PubMed ID: 38294961
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A new 7-point method facilitates accurate diagnosis of high-grade urothelial carcinoma in routine urinary cytology practice.
    Iwai S; Mimura A; Ohtani H; Shimokama T; Kinjo M
    J Am Soc Cytopathol; 2021; 10(1):103-109. PubMed ID: 33092994
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The continual impact of the Paris System on urine cytology, a 3-year experience.
    Stanzione N; Ahmed T; Fung PC; Cai D; Lu DY; Sumida LC; Moatamed NA
    Cytopathology; 2020 Jan; 31(1):35-40. PubMed ID: 31596979
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An institutional experience with The Paris System: A paradigm shift from ambiguous terminology to more objective criteria for reporting urine cytology.
    Roy M; Kaushal S; Jain D; Seth A; Iyer VK; Mathur SR
    Cytopathology; 2017 Dec; 28(6):509-515. PubMed ID: 28833848
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A real-world study of the clinical application of the Paris system for reporting urinary cytology in cancer hospital].
    Zhao H; Zhang ZH; Guo HQ; Wei N; Ma HY; Zhao LL; Sun Y; Wang C; Chang XX; Bi XG; Xing NZ
    Zhonghua Zhong Liu Za Zhi; 2024 Jul; 46(7):703-709. PubMed ID: 39034806
    [No Abstract]   [Full Text] [Related]  

  • 27. Clinical follow up and the impact of the Paris system in the assessment of patients with atypical urine cytology.
    Northrup V; Acar BC; Hossain M; Acker MR; Manuel E; Rahmeh T
    Diagn Cytopathol; 2018 Dec; 46(12):1022-1030. PubMed ID: 30375194
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytologic evaluation of upper urinary tract specimens: An institutional retrospective study using The Paris System for Reporting Urine Cytology second edition with histopathologic follow-up.
    Khajir G; Sun T; Wang H; Sprenkle PC; Adeniran AJ; Cai G; Levi AW
    Cytopathology; 2024 Mar; 35(2):235-241. PubMed ID: 37916579
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Utility of the Paris System in Urine Cytology for Improved Screening of High-Grade Urothelial Carcinoma in Bahrain.
    Mahmoud Daoud R; Ali AH; Salim Fredericks S; Daoud S; Gomaa HR; AlHashimi FS
    Cureus; 2024 Mar; 16(3):e57189. PubMed ID: 38681345
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cyto-histo correlation and false-negative urine: Before and after the Paris system for reporting urinary cytology.
    Yuan L; Gero M; Zia S; Aryal SC; Shetty S; Reynolds JP
    Diagn Cytopathol; 2022 Aug; 50(8):404-410. PubMed ID: 35652594
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of the Paris system for reporting urinary cytology with histologic follow-up.
    Rohra P; Ocampo Gonzalez FA; Yan L; Mir F; Furlan K; Basu S; Barua A; Cheng L; Park JW
    Diagn Cytopathol; 2021 Jun; 49(6):691-699. PubMed ID: 33600080
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of Implementing the Paris System for Reporting Urinary Cytology: A Single-institutional Experience With Emphasis on Diagnostic Yield of High-grade Urothelial Carcinoma and Low-grade Urothelial Neoplasm.
    Koh HH; Lee MJ; Park NJ; Kim HS; Oh YL
    Anticancer Res; 2020 Jun; 40(6):3477-3484. PubMed ID: 32487647
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improved risk stratification for patients with high-grade urothelial carcinoma following application of the Paris System for Reporting Urinary Cytology.
    Cowan ML; Rosenthal DL; VandenBussche CJ
    Cancer Cytopathol; 2017 Jun; 125(6):427-434. PubMed ID: 28272842
    [TBL] [Abstract][Full Text] [Related]  

  • 34. One year of experience using the Paris System for Reporting Urinary Cytology.
    Meilleroux J; Daniel G; Aziza J; d'Aure DM; Quintyn-Ranty ML; Basset CM; Evrard SM; Courtade-Saidi MM
    Cancer Cytopathol; 2018 Jun; 126(6):430-436. PubMed ID: 29663682
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reclassification of urinary cytology regarding The Paris System for Reporting Urinary Cytology with cytohistological correlation demonstrates high sensitivity for high-grade urothelial carcinoma.
    Anbardar MH; Monjazeb R
    Diagn Cytopathol; 2020 May; 48(5):446-452. PubMed ID: 31976626
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Are we on track for diagnosing high-grade urothelial carcinoma with a minimum quantity of five malignant cells in lower tract specimens? Critical analysis of The Paris System Quantitation Criteria.
    Folarin OS; Siddiqui MT
    Cancer Cytopathol; 2023 Nov; 131(11):708-715. PubMed ID: 37572083
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Digital image analysis supports a nuclear-to-cytoplasmic ratio cutoff value below 0.7 for positive for high-grade urothelial carcinoma and suspicious for high-grade urothelial carcinoma in urine cytology specimens.
    McIntire PJ; Snow JT; Elsoukkary SS; Soong L; Sweeney J; Robinson BD; Siddiqui MT
    Cancer Cytopathol; 2019 Feb; 127(2):120-124. PubMed ID: 30395388
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of urine cytology diagnostic reports before and after the implementation of the Paris System classification system in China.
    Ma C; Zhang L
    Cytopathology; 2020 Sep; 31(5):457-462. PubMed ID: 32246545
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cell blocks in urine cytopathology: do they add value to the diagnosis? A pilot study.
    Wilson BL; Russell D; Evans SK; Agrawal T
    J Am Soc Cytopathol; 2021; 10(1):47-55. PubMed ID: 33039333
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improved correlation of urinary cytology specimens using The Paris System in biopsy-proven upper tract urothelial carcinomas.
    McIntire PJ; Snow JT; Robinson BD; Rao RA; Goyal A; Heymann JJ; Siddiqui MT
    Cancer Cytopathol; 2018 Jul; 126(7):498-504. PubMed ID: 29927548
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.